Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis

被引：0
作者：
Federico Verde
Ilaria Milone
Eleonora Colombo
Alessio Maranzano
Antonella Dubini
Claudia Colombrita
Francesco Gentile
Alberto Doretti
Silvia Torre
Stefano Messina
Claudia Morelli
Erminio Torresani
Barbara Poletti
Alberto Priori
Luca Maderna
Antonia Ratti
Vincenzo Silani
Nicola Ticozzi
机构：
[1] IRCCS Istituto Auxologico Italiano,Department of Neurology and Laboratory of Neuroscience
[2] Università Degli Studi Di Milano,Department of Pathophysiology and Transplantation, Dino Ferrari Center
[3] IRCCS Istituto Auxologico Italiano,Laboratory of Clinical Chemistry and Microbiology, Department of Laboratory Medicine
[4] Neurology Residency Program,Department of Oncology and Hemato
[5] Università Degli Studi Di Milano,Oncology
[6] Università Degli Studi Di Milano,Aldo Ravelli Research Center for Neurotechnology and Experimental Neurotherapeutics, Department of Health Sciences
[7] Università Degli Studi Di Milano,Department of Medical Biotechnology and Translational Medicine
[8] III Neurology Clinic,undefined
[9] ASST Santi Paolo E Carlo University Hospital,undefined
[10] Università Degli Studi Di Milano,undefined
来源：
Neurological Sciences | 2023年 / 44卷
关键词：
Phosphorylated tau (P-tau181); Amyotrophic lateral sclerosis (ALS); Plasma; Biomarker; Lower motor neuron (LMN);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3697 / 3702
页数：5
相关论文
共 38 条
  • [1] Cousins KAQ(2022)Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis Ann Neurol 92 807-818
  • [2] Shaw LM(2023)Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 94 428-435
  • [3] Shellikeri S(2022)Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease Alzheimers Res Ther 14 172-852
  • [4] Vacchiano V(2023)Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis Front Aging Neurosci 15 1132808-511
  • [5] Mastrangelo A(2012)A proposed staging system for amyotrophic lateral sclerosis Brain 135 847-518
  • [6] Zenesini C(2020)Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis Muscle Nerve 61 508-612
  • [7] Baiardi S(2023)Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis J Neurol 270 511-498
  • [8] Avoni P(2009)A new equation to estimate glomerular filtration rate Ann Intern Med 150 604-174
  • [9] Polischi B(2016)The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) Amyotroph Lateral Scler Frontotemporal Degener 17 489-undefined
  • [10] Capellari S(2017)Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria Amyotroph Lateral Scler Frontotemporal Degener 18 153-undefined
1234